Drug Profile
Deltibant
Alternative Names: Bradycor; CP 0127; SB 238592; SepticorLatest Information Update: 28 Sep 1998
Price :
$50
*
At a glance
- Originator Cortech
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Bradykinin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Brain injuries; Brain oedema; Cancer pain; Migraine; Postoperative pain; Shock; Stroke; Systemic inflammatory response syndrome
Most Recent Events
- 28 Sep 1998 Discontinued-III for Systemic inflammatory response syndrome in USA (Unknown route)
- 28 Sep 1998 Discontinued-Preclinical for Shock in USA (Unknown route)
- 28 Sep 1998 Discontinued-Unspecified for Asthma in USA (Unknown route)